✦ LIBER ✦

Rituximab in B-Cell chronic lymphocytic leukemia

✍ Scribed by Thomas S Lin; Margaret S Lucas; John C Byrd

Book ID: 114106630
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 108 KB
Volume: 30
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(03)00239-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase III trial of fludarabine, cyclop

A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia

✍ Craig Reynolds, Nicholas Di Bella, Roger M. Lyons, William Hyman, Donald A. Rich 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 160 KB

Involvement of Tis11b, an AU-rich bindin

Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells

✍ Baou, M; Jewell, A; Muthurania, A; Wickremasinghe, R G; Yong, K L; Carr, R; Mars 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Intractable Autoimmune Hemolytic Anemia

Intractable Autoimmune Hemolytic Anemia in B Cell Chronic Lymphocytic Leukemia Resolved by Rituximab

✍ Shvidel, Lev; Shtalrid, Mordechai; Berrebi, Alain 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 105 KB

Consolidation and maintenance immunother

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia

✍ Giovanni Del Poeta; Maria Ilaria Del Principe; Francesco Buccisano; Luca Maurill 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## BACKGROUND. Rituximab in sequential combination with fludarabine (Flu) allowed patients with B‐cell chronic lymphocytic leukemia (B‐CLL) to achieve higher remission rates and longer response duration. Based on their recent experience in indolent non‐Hodgkin lymphomas, in this study,

Effective treatment of leukemia cutis wi

Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia

✍ Aleksandra Batycka-Baran; Wojciech Baran; Justyna Dzietczenia; Grzegorz Mazur 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 138 KB

Rituximab and alemtuzumab induce a noncl

Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells

✍ Michael Stanglmaier; Simone Reis; Michael Hallek 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 433 KB